Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "AbCellera Biologics"


2 mentions found


Chipmaker Nvidia will invest $50 million in Recursion Pharmaceuticals to speed up the development of the biotech firm's artificial intelligence models for drug discovery, the companies said Wednesday. AI models usually require vast amounts of data, typically measured in terabytes, to train them. Nvidia can then potentially license those AI models on BioNeMo, the company's cloud service for generative AI in drug discovery that it rolled out earlier this year. A month later, Google Cloud launched two new AI-powered tools that aim to help biotech and pharmaceutical companies accelerate drug discovery. The company in May acquired two companies in the AI-driven drug discovery space for $87.5 million.
Persons: Roche, Chris Gibson, Nvidia's, drugmakers, Exscientia, AbCellera Biologics, — CNBC's Benjamin Taubman Organizations: Nvidia, Pharmaceuticals, Bayer, NVIDIA, Moderna, Google Cloud Locations: Salt Lake City , Utah
A report from data analytics firm Verity shows that some corporate insiders made stock buys this year that have already doubled in value. Many professional investors track insider buying and selling as a measure of a company's quality. Verity compiled insider-buying data from securities filings to show the best insider stock buys of the year. Some notable insiders buying at biotech companies include AbCellera Biologics CFO Andrew Booth and Iveric Bio director Calvin Roberts. The top two insider buys in the S & P 500 came from directors of Genuine Parts .
Total: 2